Please assess the completion status of the following clinical trial:

Trial Title: The Prevention of Osteoporosis in Premenopausal and Newly Postmenopausal (Up to 8 Years) Women With Breast Cancer Following Chemotherapy (REBBeCA Study)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Pre- and newly postmenopausal (up to 8 years) women ages 18 and older~* Breast cancer treated with chemotherapeutic agents, with or without tamoxifen/aromatase inhibitors~* Negative pregnancy test~Exclusion Criteria:~* Stage 4 breast cancer~* Any illness or medications known to affect bone metabolism~* History of osteoporosis or history of vertebral or hip fractures~* Kidney stones in the past 5 years~* Active peptic ulcer disease

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- A (Type: PLACEBO_COMPARATOR): Group A will receive active study drug

Based on this trial design, predict the completion outcome and termination type (if applicable).